Applications of the HSA/hFcRn mouse model

Broad range of applications in the fields of immuno-oncology, infectious diseases and autoimmunity:

  • Assess pharmacokinetics and pharmacodynamics (PK/PD) features, including biodistribution and binding affinity
  • Screen compounds based on extended half-life
  • Assess the efficacy of optimized therapeutics such as Fc-engineered antibodies, constructs fused to HSA, HSA- and/or FcRn-binding proteins or small molecules

Features

  • Physiological expression and distribution of HSA and human FcRn
  • Lack of expression of the murine target genes
  • Higher physiological affinity of human serum albumin to human FcRn
  • Unaltered blood chemistry compared to a wild-type mouse

Related resources and publications

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
No results

Validation data

Discover related products to

HSA/hFcRn

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
HSA
PK/PD
Fc receptor
KO-Rep-Mix

HSA/hFcRn-Rag1-KO

This upgraded, immunocompromised Rag1-/- version of our HSA/hFcRn mouse model allows the assessment of compounds' half-life and anti-tumor efficacy in a human tumor model.

FcgR
Fc receptor

hFcγR

Preclinical humanized Fc-gamma receptor (hFcγR) model enabling the assessment of Fc receptor pathways targeted therapies.

Inflammation
IgE
FceR1
Fc receptor
Allergy

hIgE/hFcεR1

Use the hIgE/hFcεR1 mouse model to successfully screen for innovative therapeutics for allergy, asthma and other IgE-mediated diseases.

Double-humanized HSA/hFcRn mouse model

Get in touch about

Let us know how we can help

In order to provide you the content requested, we need to store and process your personal data. If you consent to us storing your personal data for this purpose, please tick the checkbox below.

From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please tick below.

You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.